Direct costs in diabetic and non diabetic people: The population-based Turin study, Italy

Abstract

Direct costs are 4-fold higher in diabetic than in non diabetic people, mainly due to care of the elderly and inpatient care. In developed countries, demographic changes will have a profound impact on costs for diabetes in next years.

Prevalence of diabetes across different immigrant groups in North-eastern Italy

“…Such differences should be taken into account in shaping primary prevention campaigns targeting obesity and physical inactivity [14], in the design of differential screening strategies for diabetes [12], in recognizing an increasing demand for health care in selected population groups, to guarantee that resource allocation is directed by medical requirements [5], in view of the high costs associated to the care of diabetic patients [15].…”

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in the Russian Federation: Results from Russian multicenter observational pharmacoepidemiologic study of diabetes care for patients with type 2 diabetes mellitus (FORSIGHT-Т2DM)

“…прямые затраты на 1 больного с СД2 составляли $7888 [24], в Ита-лии -€3660,8 (2012 г.) [26], в Южной Корее -$1938,8 [27], в Германии -5262 € [28], в Испании в 2011 г. -€3110,1 [29].…”

“…-€3110,1 [29]. Следует отметить, что прямые затраты на лечение боль-ных СД2 по данным зарубежных источников в 2-4 раза превышают затраты на лечение больных, не страдающих данным заболеванием [24,26,27,29].…”

A Multicenter Italian Survey on Diabetes Care Units Reveals a Somewhat Slow Attitude in Treatment Guideline Implementation: Are We Dealing With Therapeutic Inertia?

“…30 We hypothesized that in people with type 2 diabetes, this might be obtained by an early integration between GPs and diabetes care teams. Table 6: Treatment choices (%) after referral with respect to complication (compare with Table 5).…”